Aktiebolaget Hassle

Aktiebolaget Astra

John A Sjogren

John A Sandberg

Curt H Appelgren

Gert A Ragnarsson

Conny B Bogentoft

Lars-Erik D Dahlinder

Eva Kristina Byrod

Karl-Erik L Falk

Adam Rosinski

Mats O Johansson

Ulf E Jonsson

Kajsa M Silfverstrand

Sven M Hugosson

Controlled release preparation containing a number of insoluble beads applied with one or more pharmaceutically active compounds, a method for the production thereof and the use in a treatment where a controlled release of a pharmaceutically active compound is needed.

Drug preparation

Controlled release preparation containing a number of beads comprising a salt of metoprolo as the main soluble component, a method for the production thereof and the use in the treatment of cardiovascular disorders.

Pharmaceutical preparation

Preparation giving a controlled and extended release of both a dihydropyridine, e.g. felodipine and a .beta.-adrenoreceptor antagonist, namely metoprolol as well as a method for the manufacture of the new preparation.

Pharmaceutical preparation and a process for its preparation

An extended release perparation of an active compound with very low solubility containing the active compound dissolved or dispersed in a semi-solid or liquid non-ionic solubilizer and whereby the amount by weight of the solubilizer is at least equal to the amount by weight of the active compound as well as a process for the preparation thereof.

New pharmaceutical preparations with extended release

The present invention relates to gastric acid neutralizing compositions comprising dried aluminum hydroxide in suspension form, whereby the composition as suspension stabilizing and suspension forming agent comprises a hydrogenated, hydrolyzed glucose polymer in an amount of 2 to 30% by weight. By way of this content of the glucose polymer the amount of gastric acid neutralizing substance can be increased whereby smaller doses can be administered in obtaining gastric acid neutralization.

Process for the preparation of gastric acid neutralizing agents, gastric

A solid pharmaceutical preparation for administration in dosage unit form comprising a therapeutically effective cardiac glycoside, whereby each dosage unit is to comprise a plurality of bodies, each of said bodies having a pharmaceutically indifferent core, a first layer thereon containing the glycoside and a second layer containing a polymer insoluble in gastric juice and soluble in intestinal juice, a process for preparing such preparation and a method of treatment employing the same.

Growing community of inventors

Molnlycke, Sweden

John A Sjogren